Ameriprise’s Rosetta Genomics ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
HCM
Ameriprise's ROSG Position: Q2 2014 in Review
Ameriprise sold out of Rosetta Genomics (ROSG) in Q2 2014, closing a stake of 17 shares — an estimated $1K sold.
Ameriprise first reported a position in ROSG in Q1 2014 and held it in 1 quarter. The position peaked at $1K in Q1 2014. 16 funds tracked by Wall St. Rank hold ROSG as of Q2 2014.
- Ameriprise reported no remaining Rosetta Genomics position as of Q2 2014 after selling out during the quarter.
- Ameriprise sold 17 Rosetta Genomics shares in Q2 2014, an estimated $1K.
- Ameriprise first reported a position in Rosetta Genomics in Q1 2014 and held it in 1 quarter.
- Ameriprise's Rosetta Genomics position peaked at $1K in Q1 2014.
- 16 funds tracked by Wall St. Rank held Rosetta Genomics as of Q2 2014.
Based on Ameriprise's 13F filing for Q2 2014, filed 13 Aug 2014.